Drugs Made In America Acquisition Corp. (DMAAU) Long-Term Debt Issuances (2025)

Drugs Made In America Acquisition (DMAAU) has 1 years of Long-Term Debt Issuances data on file, last reported at $900000.0 in Q1 2025.

• Quarterly Long-Term Debt Issuances changed N/A year-over-year to $900000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $900000.0 (changed N/A YoY) and the FY2025 annual result came in at $900000.0, down 30.79% from the prior year.
• Long-Term Debt Issuances steadied at $900000.0 in Q1 2025.
• In the past five years, Long-Term Debt Issuances ranged from a high of $900000.0 in Q1 2025 to a low of $900000.0 in Q1 2025.